GeoVax Labs Return on Equity (ROE) Growth & History (GOVX)
GeoVax Labs's return on equity was −483.79% for fiscal 2025.
View full GeoVax Labs company overviewGeoVax Labs annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −483.79% | −21.47 pp |
| 2024 | 2024-12-31 | −462.31% | −301.84 pp |
| 2023 | 2023-12-31 | −160.47% | −69.90 pp |
| 2022 | 2022-12-31 | −90.57% | +176.04 pp |
| 2021 | 2021-12-31 | −266.61% | −192.61 pp |
| 2020 | 2020-12-31 | −74.00% | — |
| 2016 | 2016-12-31 | −452.84% | −224.04 pp |
| 2015 | 2015-12-31 | −228.80% | −79.97 pp |
| 2014 | 2014-12-31 | −148.83% | −24.59 pp |
| 2013 | 2013-12-31 | −124.24% | +106.02 pp |
| 2012 | 2012-12-31 | −230.26% | −45.46 pp |
| 2011 | 2011-12-31 | −184.80% | −86.34 pp |
| 2010 | 2010-12-31 | −98.46% | +3.31 pp |
| 2009 | 2009-12-31 | −101.77% | +37.40 pp |
| 2008 | 2008-12-31 | −139.17% | +35.71 pp |
| 2007 | 2007-12-31 | −174.88% | −106.26 pp |
| 2006 | 2006-12-31 | −68.62% | — |
| 2004 | 2004-12-31 | −974.01% | −160.51 pp |
| 2003 | 2003-12-31 | −813.50% | — |
GeoVax Labs quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −392.69% | −292.50 pp |
| Q1 2026 | 2026-03-31 | −243.67% | −160.90 pp |
| Q4 2025 | 2025-12-31 | −101.20% | +20.74 pp |
| Q3 2025 | 2025-09-30 | −163.53% | +24.23 pp |
| Q2 2025 | 2025-06-30 | −100.19% | — |
| Q1 2025 | 2025-03-31 | −82.77% | +118.35 pp |
| Q4 2024 | 2024-12-31 | −121.94% | −19.91 pp |
| Q3 2024 | 2024-09-30 | −187.76% | −123.77 pp |
| Q1 2024 | 2024-03-31 | −201.12% | −184.79 pp |
| Q4 2023 | 2023-12-31 | −102.03% | −83.59 pp |
| Q3 2023 | 2023-09-30 | −63.99% | −50.68 pp |
| Q2 2023 | 2023-06-30 | −29.62% | −18.19 pp |
| Q1 2023 | 2023-03-31 | −16.33% | +14.57 pp |
| Q4 2022 | 2022-12-31 | −18.44% | +104.45 pp |
| Q3 2022 | 2022-09-30 | −13.30% | −2.89 pp |
| Q2 2022 | 2022-06-30 | −11.43% | −4.88 pp |
| Q1 2022 | 2022-03-31 | −30.89% | −20.55 pp |
| Q4 2021 | 2021-12-31 | −122.89% | −109.78 pp |
| Q3 2021 | 2021-09-30 | −10.41% | +2.32 pp |
| Q2 2021 | 2021-06-30 | −6.55% | — |
| Q1 2021 | 2021-03-31 | −10.34% | — |
| Q4 2020 | 2020-12-31 | −13.11% | — |
| Q3 2020 | 2020-09-30 | −12.73% | — |
| Q3 2017 | 2017-09-30 | −1,148.68% | −989.02 pp |
| Q2 2017 | 2017-06-30 | −1,097.49% | −951.50 pp |
| Q4 2016 | 2016-12-31 | −282.18% | −237.26 pp |
| Q3 2016 | 2016-09-30 | −159.67% | −131.25 pp |
| Q2 2016 | 2016-06-30 | −145.99% | −121.95 pp |
| Q1 2016 | 2016-03-31 | −141.31% | −108.65 pp |
| Q4 2015 | 2015-12-31 | −44.92% | +46.12 pp |
| Q3 2015 | 2015-09-30 | −28.42% | +19.09 pp |
| Q2 2015 | 2015-06-30 | −24.04% | +18.16 pp |
| Q1 2015 | 2015-03-31 | −32.67% | −5.08 pp |
| Q4 2014 | 2014-12-31 | −91.04% | −50.14 pp |
| Q3 2014 | 2014-09-30 | −47.51% | −37.03 pp |
| Q2 2014 | 2014-06-30 | −42.20% | −13.54 pp |
| Q1 2014 | 2014-03-31 | −27.59% | +19.96 pp |
| Q4 2013 | 2013-12-31 | −40.90% | +1.93 pp |
| Q3 2013 | 2013-09-30 | −10.48% | +5.97 pp |
| Q2 2013 | 2013-06-30 | −28.66% | −5.17 pp |
| Q1 2013 | 2013-03-31 | −47.55% | +0.66 pp |
| Q4 2012 | 2012-12-31 | −42.83% | +80.79 pp |
| Q3 2012 | 2012-09-30 | −16.45% | +12.84 pp |
| Q2 2012 | 2012-06-30 | −23.49% | −10.45 pp |
| Q1 2012 | 2012-03-31 | −48.21% | — |
| Q4 2011 | 2011-12-31 | −123.61% | — |
| Q3 2011 | 2011-09-30 | −29.29% | — |
| Q2 2011 | 2011-06-30 | −13.05% | — |
GeoVax Labs return on equity trends
Over the last five fiscal years, GeoVax Labs's return on equity decreased from −74.00% to −483.79%, a change of −409.78 percentage points. The latest reported quarter, Q2 2026, shows −392.69%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeoVax Labs source filings ↗